STORY FROM: Drugs & Medical Devices

9th Cir. Panel Upholds Dismissal of Medtronic Drug-Infusion Pump Action

SAN FRANCISCO — A federal appeals panel has upheld dismissal of state law claims in a Medtronic drug-infusion pump case, finding the manufacturer complied with federal law by filing adverse event reports with the Food and Drug Administration.

In a Jan. 28 opinion, the 9th Circuit U.S. Court of Appeals panel further found the plaintiff failed to adequately specify the nature of the device’s alleged defects and did not demonstrate a genuine dispute of material fact over whether she justifiably relied upon any of Medtronic’s statements.

Rebeca Lawrence sued Medtronic in the U.S. District Court for the Central District of ...

Associated Documents

Registered User Login